ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 636 filers reported holding ISHARES TR in Q4 2017. The put-call ratio across all filers is 2.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $350,000 | -2.5% | 2,585 | -1.6% | 0.16% | +8.7% |
| Q2 2020 | $359,000 | -39.6% | 2,627 | -52.4% | 0.15% | -50.3% |
| Q1 2020 | $594,000 | +5.5% | 5,515 | +18.0% | 0.30% | +30.7% |
| Q4 2019 | $563,000 | -0.2% | 4,672 | -17.6% | 0.23% | -6.5% |
| Q3 2019 | $564,000 | -14.7% | 5,672 | -6.4% | 0.25% | -16.0% |
| Q2 2019 | $661,000 | -2.5% | 6,062 | 0.0% | 0.29% | -5.5% |
| Q1 2019 | $678,000 | +15.9% | 6,062 | 0.0% | 0.31% | +1.3% |
| Q4 2018 | $585,000 | -20.8% | 6,062 | 0.0% | 0.31% | -13.3% |
| Q3 2018 | $739,000 | +24.4% | 6,062 | +12.0% | 0.35% | +19.2% |
| Q2 2018 | $594,000 | +2.4% | 5,411 | -0.5% | 0.30% | +0.3% |
| Q1 2018 | $580,000 | +39.8% | 5,439 | +41.9% | 0.30% | -19.8% |
| Q4 2017 | $415,000 | -10.9% | 3,833 | +179.0% | 0.37% | -18.9% |
| Q3 2017 | $466,000 | -4.1% | 1,374 | -12.5% | 0.46% | +2.5% |
| Q2 2017 | $486,000 | -3.6% | 1,571 | -10.5% | 0.44% | -5.3% |
| Q1 2017 | $504,000 | – | 1,755 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |